Complete resolution of a cutaneous grade 2 graft-versus-host disease after liver transplantation using ruxolitinib

Clin Transplant. 2021 Aug;35(8):e14366. doi: 10.1111/ctr.14366. Epub 2021 Jun 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Graft vs Host Disease* / drug therapy
  • Graft vs Host Disease* / etiology
  • Humans
  • Liver Transplantation*
  • Nitriles
  • Pyrazoles / therapeutic use
  • Pyrimidines
  • Skin Diseases*

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib